Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study).
Tamberella
Michael R
MR
Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA., USA
Bhatt
Deepak L
DL
Chew
Derek P
DP
Kereiakes
Dean J
DJ
Topol
Eric J
EJ
Steinhubl
Steven R
SR
D015906:Angioplasty, Balloon, Coronary; D001792:Blood Platelets / Q000187:drug effects / Q000502:physiology; D005260:Female; D006331:Heart Diseases / Q000517:prevention & control*; D006470:Hemorrhage / Q000209:etiology* / Q000517:prevention & control*; D006801:Humans; D008297:Male; D010974:Platelet Aggregation / Q000187:drug effects; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D011446:Prospective Studies
D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex